| Lot Release Number |
2020-07-27-0205
|
| FDA Registered Product/Generic Name |
Omalizumab
|
| Brand Name |
Xolair
|
| Dosage Strength |
202.5 mg
|
| Dosage Form |
Lyophilized Powder for Injection (S.C.)
|
| Registration Number |
BR-987
|
| Batch/Lot Number |
SWW59
|
| Packaging Lot |
Packaging Lot: Box - SWW59; Vial - SWW59 (MD: 03 2020; ED: 02 2024); ampoule - 11524376 (MD: 07 2018; ED: 06 2023)
|
| Product Expiration Date |
30 June 2023
|
| Issuance Date |
19 August 2020
|